IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM

IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM was reported 22 times

IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDICAL DEVICE SITE EROSION 1 0.0083
1 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
2 RECTAL NEOPLASM 1 0.0038
3 LARYNGOMALACIA 1 0.0030
4 LIFE EXPECTANCY SHORTENED 1 0.0018
5 UTERINE CYST 1 0.0018
6 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
7 PRODUCT SHAPE ISSUE 1 0.0011
8 PREMENSTRUAL SYNDROME 1 0.0007
9 COSTOCHONDRITIS 1 0.0006
10 HEPATIC MASS 1 0.0005
11 MENOPAUSE 1 0.0004
12 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
13 HYPOMENORRHOEA 1 0.0004
14 VENOUS THROMBOSIS 1 0.0003
15 GASTRITIS EROSIVE 1 0.0002
16 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
17 RENAL CELL CARCINOMA 1 0.0002
18 PANCREATIC DISORDER 1 0.0002
19 VEIN DISORDER 1 0.0002
20 FAILURE TO THRIVE 1 0.0002
21 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
23 AUTOIMMUNE HEPATITIS 1 0.0001
24 TENDON PAIN 1 0.0001
25 CONGENITAL ANOMALY 1 0.0001
26 BLOOD ALBUMIN DECREASED 1 0.0001
27 SECOND PRIMARY MALIGNANCY 1 0.0001
28 UTERINE PERFORATION 1 0.0001
29 IRON DEFICIENCY ANAEMIA 1 0.0001
30 PRODUCT PACKAGING ISSUE 1 0.0001
31 VAGINAL DISCHARGE 1 0.0001
32 HELICOBACTER INFECTION 1 0.0001
33 WEIGHT FLUCTUATION 1 0.0001
34 CHOLECYSTITIS 1 0.0001
35 BURSITIS 1 0.0001
36 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
37 PREMATURE DELIVERY 1 0.0001
38 BLOOD POTASSIUM INCREASED 1 0.0001
39 HEPATIC CIRRHOSIS 1 0.0001
40 SLEEP APNOEA SYNDROME 1 0.0001
41 RETCHING 1 0.0000
42 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
43 GASTRITIS 1 0.0000
44 CHOLELITHIASIS 1 0.0000
45 HEPATIC ENZYME INCREASED 2 0.0000
46 PLASMA CELL MYELOMA 1 0.0000
47 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
48 EXTRA DOSE ADMINISTERED 1 0.0000
49 VAGINAL HAEMORRHAGE 1 0.0000
50 DEVICE DISLOCATION 1 0.0000
51 SKIN IRRITATION 1 0.0000
52 BLOOD CHOLESTEROL INCREASED 1 0.0000
53 PRODUCTIVE COUGH 1 0.0000
54 LUNG DISORDER 1 0.0000
55 FLUSHING 2 0.0000
56 INFLAMMATION 1 0.0000
57 DRUG EFFECT DECREASED 1 0.0000
58 PANCYTOPENIA 1 0.0000
59 OEDEMA PERIPHERAL 2 0.0000
60 DISCOMFORT 1 0.0000
61 MUSCLE SPASMS 3 0.0000
62 FEELING HOT 1 0.0000
63 RHINORRHOEA 1 0.0000
64 PRODUCT DOSE OMISSION 1 0.0000
65 BLOOD CREATININE INCREASED 1 0.0000
66 PRODUCT QUALITY ISSUE 2 0.0000
67 SLEEP DISORDER 1 0.0000
68 THERAPY INTERRUPTED 1 0.0000
69 THROMBOSIS 1 0.0000
70 CARDIAC ARREST 1 0.0000
71 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
72 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
73 DYSPEPSIA 1 0.0000
74 ABDOMINAL PAIN UPPER 2 0.0000
75 DEPRESSION 2 0.0000
76 DISEASE PROGRESSION 1 0.0000
77 ASTHENIA 3 0.0000
78 HYPERHIDROSIS 1 0.0000
79 DRY SKIN 1 0.0000
80 INFECTION 1 0.0000
81 BLOOD PRESSURE INCREASED 1 0.0000
82 HOSPITALISATION 1 0.0000
83 PERIPHERAL SWELLING 1 0.0000
84 PARAESTHESIA 1 0.0000
85 TREMOR 1 0.0000
86 URTICARIA 1 0.0000
87 ABDOMINAL DISCOMFORT 1 0.0000
88 URINARY TRACT INFECTION 1 0.0000
89 HYPERSENSITIVITY 1 0.0000
90 BLOOD GLUCOSE INCREASED 1 0.0000
91 PRURITUS 2 0.0000
92 SOMNOLENCE 1 0.0000
93 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
94 DECREASED APPETITE 1 0.0000
95 BACK PAIN 1 0.0000
96 FEELING ABNORMAL 1 0.0000
97 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
98 FATIGUE 3 0.0000
99 COUGH 1 0.0000
100 PAIN IN EXTREMITY 1 0.0000
101 PNEUMONIA 1 0.0000
102 RASH 1 0.0000
103 MALAISE 1 0.0000
104 VOMITING 1 0.0000
105 DYSPNOEA 1 0.0000
106 PAIN 1 0.0000
107 DIARRHOEA 1 0.0000
108 NAUSEA 1 0.0000